Details of the Drug Combinations

General Information of This Drug (ID: DMSWUGE)

Drug Name

Telbivudine DMSWUGE

Synonyms

Epavudine; LLT; LdT; Sebivo; Telbivudin; Tyzeka; Telbivudine [USAN]; LDT600; NB 02B; NV 02B; L-Deoxythymidine; L-Thymidine; L-dT; LDT-600; NV-02B; Tyzeka (TN); Beta-L-Thymidine; Telbivudine (USAN/INN); Tyzake/Sebivo (TN); Tyzeka, Sebivo, Telbivudine; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione; 2'-Deoxy-L-thymidine

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Antiviral Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Tenofovir + Telbivudine	DCWX983	Tenofovir	Chronic Hepatitis B	[2]
Tenofovir disoproxil + Telbivudine	DCCGKED	Tenofovir disoproxil	Hepatitis B, Chronic	[3]
Tenofovir disoproxil + Telbivudine	DCRPXEI	Tenofovir disoproxil	Chronic Hepatitis B	[4]
------------------------------------------------------------------------------------

References

1	Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B. Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8.
2	ClinicalTrials.gov (NCT01588912) Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir
3	ClinicalTrials.gov (NCT03468907) The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation
4	ClinicalTrials.gov (NCT02774837) Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B